Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Neoplasms 2Uterine Cervical Dysplasia 1Sarcoma 1Neoplasms, Glandular and Epithelial 1Neoplasms, Germ Cell and Embryonal 1Hodgkin Disease 1Central Nervous System Neoplasms 1Carcinoma 1

Interventions

Imiquimod 4Vaccines 3GX-188 vaccine 3Papanicolaou Test 2Colposcopy 2poly ICLC 1nimotuzumab 1efineptakin alfa 1Vaginal Smears 1Transcription Activator-Like Effector Nucleases 1TachoSil 1Surveys and Questionnaires 1Papillomavirus Vaccines 1Ocoxin 1Mindfulness 1Laser Therapy 1Interviews as Topic 1High-Intensity Focused Ultrasound Ablation 1HIV Testing 1GPI0100 1Exercise 1Cryotherapy 1Cisplatin 1CRISPR-Associated Protein 9 1Brachytherapy 1Antigens 1Adjuvants, Pharmaceutic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Uterine Cervical Dysplasia × Ocoxin × Clear all
NCT03549273 2024-02-07

Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial Lesions

Catalysis SL

Phase 2 Unknown
62 enrolled
Gynecologic

Carcinoma, Uterine Cervical Dysplasia, Neoplasms, Neoplasms, Glandular and Epithelial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡